4
MARKET OVERVIEW
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Captures industry movement, adoption patterns, and strategic signals across key end-use segments and regions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS INDICATORS
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN EUROPE HEALTHCARE INDUSTRY
5.2.4
TRENDS IN EUROPE MEDICAL DEVICE INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION (2023-2025)
5.6.2
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, (2023-2025)
5.7.1
IMPORT SCENARIO (HS CODE 9018)
5.7.2
EXPORT SCENARIO (HS CODE 9018)
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.11
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
5.12
IMPACT OF 2025 US TARIFF – EUROPE INFUSION PUMP MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES
5.12.5
IMPACT ON END-USE INDUSTRIES
5.12.5.2
HOME CARE SETTINGS
5.12.5.3
AMBULATORY CARE SETTINGS
5.12.5.4
ACADEMIC AND RESEARCH INSTITUTES
5.12.5.5
ONCOLOGY CENTERS
NOTE: OTHER END USERS INCLUDE SPECIALTY CLINICS, DIAGNOSTIC/ IMAGING CENTERS, AND LONG-TERM CARE FACILITIES.
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
SMART INFUSION SYSTEMS
6.1.2
CLOSED-LOOP INFUSION CONTROL
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
DOSE ERROR REDUCTION SYSTEMS
6.2.2
WIRELESS CONNECTIVITY
6.3
ADJACENT TECHNOLOGIES
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON EUROPE INFUSION PUMP MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
BEST PRACTICES IN EUROPE INFUSION PUMP MARKET
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN THE EUROPE INFUSION PUMP MARKET
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN EUROPE INFUSION PUMP MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
ENERGY-EFFICIENT SYSTEM DESIGN AND USE OF RECYCLABLE MATERIALS IN INFUSION PUMP PRODUCTS
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
EUROPE INFUSION PUMP MARKET, BY PRODUCT (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY INFUSION PUMP PRODUCTS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS MANUFACTURER COMPANIES
Market Size, Volume & Forecast – USD Million
9.2
VOLUME ANALYSIS OF INFUSION PUMP PRODUCTS, 2024 – 2031 (THOUSAND UNITS)
9.3
ACCESSORIES AND CONSUMABLES
9.3.1
DEDICATED ACCESSORIES AND CONSUMABLES
9.3.1.1
VOLUMETRIC INFUSION PUMP DEDICATED DISPOSABLES
9.3.1.2
INSULIN PUMP DEDICATED DISPOSABLES
9.3.1.3
ENTERAL INFUSION PUMP DEDICATED DISPOSABLES
9.3.1.4
SYRINGE INFUSION PUMP DEDICATED DISPOSABLES
9.3.1.5
AMBULATORY INFUSION PUMP DEDICATED DISPOSABLES
9.3.1.6
PCA PUMP DEDICATED DISPOSABLES
9.3.1.7
IMPLANTABLE INFUSION PUMP DEDICATED DISPOSABLES
9.3.2
NON-DEDICATED ACCESSORIES AND CONSUMABLES
9.3.2.1
INFUSION CATHETERS
9.3.2.2
IV/ADMINISTRATION SETS
9.3.2.3
NEEDLELESS CONNECTORS
9.3.2.5
TUBING AND EXTENSION SETS
9.3.2.7
OTHER NON-DEDICATED ACCESSORIES AND CONSUMABLES
NOTE: OTHER NON-DEDICATED ACCESSORIES AND CONSUMABLES INCLUDE NEEDLES, RESERVOIR BAGS AND CONTAINERS, FILTERS, FITTINGS, AND ADAPTERS.
9.4.1
DEVICES MARKET, BY TYPE
9.4.1.1
VOLUMETRIC INFUSION PUMPS
9.4.1.3
AMBULATORY INFUSION PUMPS
9.4.1.1.1
DISPOSABLE INFUSION PUMPS
9.4.1.1.2
CHEMOTHERAPY INFUSION PUMPS
9.4.1.4
SYRINGE INFUSION PUMPS
9.4.1.5
ENTERAL INFUSION PUMPS
9.4.1.7
IMPLANTABLE INFUSION PUMPS
9.4.2
DEVICES MARKET, BY TECHNOLOGY
9.4.2.1
TRADITIONAL INFUSION PUMPS
9.4.2.2
SPECIALTY INFUSION PUMPS
9.4.3
DEVICES MARKET, BY MODE
9.4.2.1
STATIONARY INFUSION PUMPS
9.4.2.2
PORTABLE INFUSION PUMPS
10
EUROPE INFUSION PUMP MARKET, BY MODE OF ADMINISTRATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
MODE OF ADMINISTRATION WISE DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING INFUSION PUMP ADOPTION IN DIVERSE INDUSTRIES
11
EUROPE INFUSION PUMP MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
APPLICATION WISE DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING INFUSION PUMP ADOPTION IN DIVERSE INDUSTRIES
11.2
CHEMOTHERAPY/ONCOLOGY
11.5
ANALGESIA/PAIN MANAGEMENT
11.6
PEDIATRICS/NEONATOLOGY
NOTE: OTHER APPLICATIONS INCLUDE INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, NEPHROLOGY THERAPY AREA, CARDIOVASCULAR THERAPY AREA, PULMONARY THERAPY AREA AND METABOLIC THERAPY AREA.
12
EUROPE INFUSION PUMP MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
12.4
AMBULATORY CARE SETTINGS
12.5
ACADEMIC AND RESEARCH INSTITUTES
NOTE: OTHER END USERS INCLUDE SPECIALTY CLINICS, DIAGNOSTIC/ IMAGING CENTERS, AND LONG-TERM CARE FACILITIES.
13
EUROPE INFUSION PUMP MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
13.2
EUROPE VOLUME ANALYSIS – 2024 – 2031 (THOUSAND UNITS)
13.3
MACROECONOMIC OUTLOOK FOR EUROPE
NOTE: REST OF EUROPE INCLUDES RUSSIA, PORTUGAL, POLAND, FINLAND, DENMARK, BELGIUM, AUSTRIA, ICELAND, IRELAND, NORWAY, AND LUXEMBOURG
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
14.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
14.3
EUROPE REVENUE SHARE ANALYSIS OF KEY PLAYERS (2021-2025)
14.4
EUROPE MARKET SHARE ANALYSIS,
14.5
BRAND COMPARATIVE ANALYSIS
16.5.3
B. BRAUN SE (PERFUSOR)
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
14.6.5.1
COMPANY FOOTPRINT
14.6.5.2
REGION FOOTPRINT
14.6.5.3
PRODUCT FOOTPRINT
14.6.5.4
MODE OF ADMINISTRATION FOOTPRINT
14.6.5.5
APPLICATION FOOTPRINT
14.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
14.7.1
PROGRESSIVE COMPANIES
14.7.2
RESPONSIVE COMPANIES
14.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.7.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
14.8
COMPANY VALUATION AND FINANCIAL METRICS
14.9
COMPETITIVE SCENARIO
14.9.4
OTHER DEVELOPMENTS
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE EUROPE INFUSION PUMP MARKET LANDSCAPE
15.8
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
15.10
F. HOFFMANN-LA ROCHE LTD
15.13
INSULET CORPORATION
15.14
TELEFLEX INCORPORATED
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
16.1.2.2
KEY PRIMARY PARTICIPANTS
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
16.1.2.4
KEY INDUSTRY INSIGHTS
16.2
MARKET SIZE ESTIMATION
16.2.1
BOTTOM-UP APPROACH
16.2.3
BASE NUMBER CALCULATION
16.3
MARKET FORECAST APPROACH
16.6
RESEARCH ASSUMPTIONS
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
17.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
17.3.2
COMPANY INFORMATION
17.3.3
GEOGRAPHIC ANALYSIS
17.3.4
COUNTRY LEVEL MARKET SHARE ANALYSIS
17.3.5
COUNTRY LEVEL VOLUME ANALYSIS
17.3.6
BY TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
17.3.7
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
*CONTENTS IN THE TOC/ MARKET SEGMENTS ARE TENTATIVE AND MIGHT CHANGE AS THE RESEARCH PROCEEDS.
*LIST OF COMPANIES IS NOT EXHAUSTIVE AND MIGHT CHANGE DURING COURSE OF STUDY
Growth opportunities and latent adjacency in Europe Infusion Pump Market